Grade 2 Meningioma — Trials

Grade 2 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02847559	Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma	completed	Phase 2	20	Northwestern UniversityOTHER	1	Sep 9, 2026	clinicaltrials
NCT01125046	Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	completed	Phase 2	50	Northwestern UniversityOTHER	1	Jan 22, 2021	clinicaltrials
NCT01024907	Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas	completed	Phase 1 / Phase 2	23	Abramson Cancer Center at Penn MedicineOTHER	1	Dec 10, 2020	clinicaltrials
NCT00045110	Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Data updated 21 days agoSource updated Sep 9, 2026source: clinicaltrials